#United States #Raleigh #Amino Acids #Quality Control #Ajinomoto

Ajinomoto Health & Nutrition North America, Inc. Opens Quality Control Laboratory

On June 4, 2025, Ajinomoto Health & Nutrition North America, Inc. (AHN), a premier name in the global amino acid manufacturing landscape, celebrated the debut of its newly renovated Quality Control Laboratory located in Raleigh, North Carolina. This event marked a significant achievement following a $2.1 million investment aimed at enhancing the facility's capabilities. The opening ceremony saw participation from global senior leaders and team members deeply involved in the renovation, symbolizing a collective commitment to quality and innovation.

The revitalization of the laboratory showcases AHN's dedication to maintaining high product quality and stringent safety standards, which are essential in today's competitive market. Jessica Lee, the Quality Manager, articulated the company's vision, stating, "By updating our facilities, we are even more equipped to meet the evolving needs of our customers and maintain our position as a leader in the industry."

With increasing demand for amino acids in various sectors, the newly improved laboratory incorporates state-of-the-art analytical equipment and optimized workflows. These enhancements not only boost efficiency but also enhance safety measures, ensuring the products meet the rigorous standards set forth by the industry.

Raleigh, known for its skilled workforce and proximity to leading universities, positions AHN favorably within a thriving biotech ecosystem. The area is home to numerous life sciences companies, which further strengthens AHN's reputation in the sector. The upgrades to the laboratory are aligned with AHN's broader growth strategy to provide Active Pharmaceutical Ingredient (API) amino acids and blends on a global scale.

By investing in these laboratory advancements, AHN is poised to meet the surging global demand for high-quality APIs while scaling production effectively. This modernization effort supports stringent quality controls, which are crucial for satisfying larger production volumes without compromising on quality. The strategic investment reflects AHN's long-standing vision for expanding its market presence and reinforcing its reputation as a reliable supplier in the pharmaceutical sector.

"The strategic investments made by AHN underscore our dedication to 'AminoScience,' the Ajinomoto Group's unique scientific approach to maximizing resources, resolving social issues, and contributing to people's wellbeing," stated Ikuo Kira, President and CEO of Ajinomoto Health & Nutrition. The Ajinomoto Group harmonizes its global divisions, delivering high-quality health and nutrition solutions by interconnecting research functions, technologies, and services centered around amino acids.

In essence, Ajinomoto Health & Nutrition North America, Inc. is not just an extension of the Ajinomoto Group but a vital player in the advancement of amino acid products across various industries. Founded in 1917 with its first U.S. office in New York, the company has significantly expanded its footprint and continues to leverage an international supply and distribution framework to provide clients with the highest-grade products. For more information about Ajinomoto Health & Nutrition, visit their official website at Ajinomoto Health & Nutrition.